| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 06/18/2009 | US20090156569 Oral contraceptive spray |
| 06/18/2009 | US20090156549 Mucosal treatment |
| 06/18/2009 | US20090156465 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 06/18/2009 | US20090155354 Dispensing encapsulated liquids into body cavities |
| 06/17/2009 | EP2070944A1 Specific binding agents of human angiopoietin-2 |
| 06/17/2009 | EP2070909A1 Non-steroidal progesterone receptor modulators |
| 06/17/2009 | EP2068891A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 06/17/2009 | EP2068881A2 Method of treating thermoregulatory disfunction with paroxetine |
| 06/17/2009 | EP1337518B1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
| 06/17/2009 | EP1322592B2 Substituted 1-aminobutan-3-ol derivatives |
| 06/17/2009 | CN100500692C Novel LHRH antagonists, preparation method and pharmaceutical use thereof |
| 06/17/2009 | CN100500658C Pharmaceutical composition of male sexual dysfunction |
| 06/17/2009 | CN100500654C Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr) |
| 06/17/2009 | CN100500200C Fuyankang pills against gynecologic inflammation and their preparation |
| 06/17/2009 | CN100500193C Extract from decoction of rehmannia including six elements, combination of medication, and medical use |
| 06/17/2009 | CN100500151C Water-soluble medicine sublingual-medicating formulation |
| 06/17/2009 | CN100500133C Chinese medicinal compound formulation for treating gynecopathy with improved bioavailability and drug effect and preparation process thereof |
| 06/16/2009 | US7547722 Chemical compounds |
| 06/16/2009 | US7547541 In vitro fertilisation |
| 06/16/2009 | CA2476934C Stabilized tnfr-fc composition comprising arginine |
| 06/16/2009 | CA2434187C Androgenic 7-substituted 11-halogenated steroids |
| 06/16/2009 | CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 06/11/2009 | WO2009073586A1 Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels |
| 06/11/2009 | WO2009071950A1 Methods for the detection of a threatened miscarriage |
| 06/11/2009 | WO2009071308A1 Pharmaceutical containing a hormone combination having a contraceptive effect and an insulin sensitizer |
| 06/11/2009 | WO2009071252A1 Nonsteroidal progesterone receptor modulators |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149629 Corticotropin releasing factor peptide for use in the treatment of nervous system and hypertensive disorders; (cyclo 31-34)[Ac-Pro4,D-Phe12,Nle18,21,Glu31,Lys34]-sucker urotensin |
| 06/11/2009 | US20090149490 Spermicidal and/or antifungal composition and methods of using the same |
| 06/11/2009 | US20090149460 New Compounds |
| 06/11/2009 | US20090149434 Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2066677A1 Pyridooxazepine progesteron receptor modulators |
| 06/10/2009 | EP2066332A1 Flu vaccine admixture of mannan and flu antigen |
| 06/10/2009 | EP2066324A2 Cycloalkanopyrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 06/10/2009 | EP1530470B1 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 06/10/2009 | EP1319003B1 Xanthine phosphodiesterase v inhibitors |
| 06/10/2009 | DE102007058842A1 Arzneimittel Drug |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497392C Antagonistic anti-hTNFSF13b Human antibodies |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497323C New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 06/10/2009 | CN100497313C New isoquinoline compounds, their preparation method and medicine composition containing them |
| 06/10/2009 | CN100496587C Pills for mammary gland disease and its preparation |
| 06/09/2009 | US7544839 N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide; nervous system disorders; melatoninergic system disorders; industrial synthesis |
| 06/09/2009 | US7544709 Derivatives of andrimide and moiramide B having antibacterial properties |
| 06/09/2009 | CA2431125C A method for treating erectile dysfunction |
| 06/09/2009 | CA2273354C Oxyiminopregnanecarbolactones |
| 06/04/2009 | WO2009068177A1 DERIVATIVES OF 4-(2-AMINO-1 -HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 06/04/2009 | WO2008017604A3 Sandalwood aroma receptors |
| 06/04/2009 | US20090143469 Salts of nateglinide |
| 06/04/2009 | US20090143435 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090143345 Thioamide derivatives as progesterone receptor modulators |
| 06/04/2009 | CA2853152A1 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms |
| 06/04/2009 | CA2706333A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2064195A2 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and pharmaceutical formulations thereof |
| 06/03/2009 | CN101445463A Beta2-adrenergic receptor agonists |
| 06/03/2009 | CN101444519A Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 06/03/2009 | CN100493603C Gonadoliberin double-way genital regulating medicine and reproduction of fish |
| 06/03/2009 | CN100493602C Gonadoliberin double-way genital regulating medicine and reproduction of fowl |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541029 Anti-rhesus D monoclonal antibodies |
| 06/02/2009 | US7541018 Treatment process using somatostatin analogues |
| 06/02/2009 | CA2434277C Substituted alkylamine derivatives and methods of use |
| 06/02/2009 | CA2394606C New modulators of dopamine neurotransmission |
| 06/02/2009 | CA2344290C Quinazoline derivatives |
| 06/02/2009 | CA2226548C Lyophilized hepatocyte growth factor preparations |
| 05/28/2009 | WO2009066712A1 Aromatase inhibitor |
| 05/28/2009 | WO2009066102A1 Vaginal lubricant comprising hyaluronic acid |
| 05/28/2009 | WO2009019607A4 Beta adrenergic receptor ligand derivatives for modulating apoptosis |
| 05/28/2009 | US20090136527 Synthetic peptide comprising the amino acid sequence GPRLGYSWHX in which each of the amino acids are in the D-amino acid configuration and X is any amino acid; optionally conjugated to the natural gonadotropin-releasing hormone peptide; vaccines for use incontrolling fertility or heat in an animal |
| 05/28/2009 | CA2705183A1 Vaginal lubricant comprising hyaluronic acid |
| 05/27/2009 | EP2062914A2 Somatostatin-dopamine chimeric analogs |
| 05/27/2009 | EP2062878A1 Hydrazine amide derivative |
| 05/27/2009 | EP2062595A1 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 05/27/2009 | EP2062583A2 Therapeutic applications of pro-apoptotic benzodiazepines |
| 05/27/2009 | EP1615925B1 Imidazopyridine derivatives as melanocortin receptor agonists |
| 05/27/2009 | CN101443011A Use of flibanserin for the treatment of post-menopausal sexual desire disorders |
| 05/27/2009 | CN101440343A Bitter melon health wine and preparation method thereof |
| 05/27/2009 | CN101439134A Method for preparing Chinese medicine preparation |
| 05/27/2009 | CN101439130A Chinese medicinal composition for treating stagnation of vital energy, blood stasis, premature ejaculation and spermatorrhea |
| 05/27/2009 | CN101439129A Pure Chinese medicinal preparation for curing sterility and its preparation process |
| 05/27/2009 | CN101439128A Technique for preparing Linggui plaster |
| 05/27/2009 | CN101439123A Method for preparing formulation containing four ingredients |
| 05/27/2009 | CN101439118A Chinese medicine for treating damp-heat liver channel induced premature ejaculation of male |
| 05/27/2009 | CN101439116A Use of Chinese medicinal composition in preparing medicament for treating diabetes mellitus induced erectile dysfunction |
| 05/27/2009 | CN101439113A Chinese herbal medicine composition for treating spermatorrhea of male |
| 05/27/2009 | CN101439046A Application of Bingpeng San combined with zinc selenium treasure tablet in preparing medicament for treating cervical erosion |
| 05/27/2009 | CN101439008A Women's washing lotion |
| 05/27/2009 | CN100491379C Method for extracting curcumcnol, antifertility drug with curcumenol as main active ingredient for rats |
| 05/27/2009 | CN100491362C Biologically active methylene blue derivatives |
| 05/27/2009 | CN100491342C Crystalline beta2 adrenergic receptor agonist |
| 05/27/2009 | CN100490892C Method for inducing onset of reproductive cycle of female breeding animals |
| 05/27/2009 | CN100490887C Suppository and preparation thereof |
| 05/27/2009 | CN100490885C Medicine for treating hyperplasia of mammary glands and its preparing method |
| 05/27/2009 | CN100490849C Method for preparing houttuynia freeze-dried powder injection |